Suchergebnisse - "Xu, Binghe"

PubPharm (35)

1

The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer : a multicenter phase II trial

enthalten in: Nature communications | 2024

von Li, Q. | Liu, J. | Zhang, Q. | +9

2

Efficacy and safety of apatinib combined with dose-dense paclitaxel and carboplatin in neoadjuvant therapy for locally advanced triple-negative breast cancer : A prospective cohort study with propensity-matched analysis

enthalten in: International journal of cancer | 2024

von Liu, J. | He, M. | Ou, K. | +11

3

Effect of Epirubicin Plus Paclitaxel vs Epirubicin and Cyclophosphamide Followed by Paclitaxel on Disease-Free Survival Among Patients With Operable ERBB2-Negative and Lymph Node-Positive Breast Cancer : A Randomized Clinical Trial

enthalten in: JAMA network open | 2023

von Yuan, P. | Kang, Y. | Ma, F. | +8

4

Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer : A nation-wide multicenter study

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Zhai, J. | Sun, X. | Zhao, F. | +8

5

Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer

enthalten in: JAMA network open | 2022

von Mo, H. | Yan, X. | Zhao, F. | +11

6

Survival outcomes for dose-dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple-negative breast cancer : A prospective cohort study with propensity-matched analysis

enthalten in: International journal of cancer | 2022

von Xiu, M. | Zhang, P. | Wang, X. | +9

7

Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial : 8.1-year median follow-up

enthalten in: Breast cancer research and treatment | 2022

von Zheng, F. | Du, F. | Wang, W. | +14

8

Platinum-based chemotherapy in advanced triple-negative breast cancer : A multicenter real-world study in China

enthalten in: International journal of cancer | 2020

von Chen, Y. | Guan, Y. | Wang, J. | +13

9

Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Du, F. | Wang, W. | Wang, Y. | +11

10

Survival outcomes of the NeoALTTO study (BIG 1-06) : updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2019

von Huober, J. | Holmes, E. | Baselga, J. | +22